Michael Cronquist Christensen, DrPH

  • 2Articles
  • 28.3KReads1
  • 2017–2023Active
  • 6Collaborators
  • 119Citations2

About

Michael Cronquist Christensen, DrPH, is affiliated with H. Lundbeck A/S in Valby, Denmark. His publications focus on major depressive disorder (MDD), specifically examining the efficacy of vortioxetine in patients with partial response to SSRI therapy and its effects on cognitive functioning in working patients with MDD. His work appears in Psychiatrist.com and involves collaboration with co-authors such as Ioana Florea and Roger S. McIntyre.

Publications

JCP
Vortioxetine vs Desvenlafaxine in Patients With MDD
Original Research

Vortioxetine vs Desvenlafaxine in Patients With MDD

May 22, 2023

Compared with desvenlafaxine, vortioxetine was associated with higher rates of symptomatic and functional remission, better daily and social functioning, and greater treatment satisfaction in patients with major depression and...
, , , et al
JCP
Original Research

Vortioxetine and Cognition in Working Patients With MDD

January 25, 2017

Many studies have shown that people with MDD have reduced work productivity, and cognitive symptoms are common. This study looked at whether antidepressant treatment with vortioxetine would improve cognitive...
, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe